Biopharma Market Update

Stifel

Research

73 Pages

Tim Opler covers the evolving cardiovascular drug field, which is accelerating due to the high unmet need.

Key Takeaways

Cardio Mortality Still Huge: Cardiovascular disease remains the world’s leading killer with ~20 million deaths per year globally, meaning even modestly effective new drugs could impact an enormous patient population.
New Drug Mechanisms Emerging: Beyond statins and PCSK9 inhibitors, new approaches targeting pathways like Lp(a), inflammation, and RNA-based therapies are advancing, potentially addressing residual cardiovascular risk that persists even after LDL reduction.
Massive Patient Opportunity: Certain emerging targets such as Lp(a) affect roughly 20% of the global population (~1.5 billion people), creating one of the largest untapped markets in medicine if effective therapies prove successful.

Join our newsletter to have all of this content + Exclusive Newsletter Bonus Content delivered to your inbox every week

Related Content

AI
Apr 2026
Alternative Assets
Apr 2026
Scroll to Top